Plant ID: NPO29935
Plant Latin Name: Caesalpinia sappan
Taxonomy Genus: Caesalpinia
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TDP1; HPGD; ALOX15; NOX4; ALDH1A1; | |
MET; ERBB2; EGFR; FGFR1; FLT1; KIT; KDR; SRC; | |
CA2; CA1; CA12; CA9; CA14; CA5B; CA5A; CA3; CA7; CA4; CA6; | |
KDM4E; | |
PLG; | |
FUT7; | |
LMNA; MAPT; | |
XDH; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
Protein Kinase | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | P04626 | CHEMBL1824 |
Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
Protein Kinase | FGFR1 | Fibroblast growth factor receptor 1 | P11362 | CHEMBL3650 |
Protein Kinase | FLT1 | Vascular endothelial growth factor receptor 1 | P17948 | CHEMBL1868 |
Protein Kinase | KIT | Stem cell growth factor receptor | P10721 | CHEMBL1936 |
Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Protein Kinase | SRC | Tyrosine-protein kinase SRC | P12931 | CHEMBL267 |
Serine protease | PLG | Plasminogen | P00747 | CHEMBL1801 |
Transferase | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Q11130 | CHEMBL3596077 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | Unclassified; | GO:0004716; signal transducer, downstream of receptor, with protein tyrosine kinase activity | 5.923E-10 | 8.061E-07 | EGFR, ERBB2, KDR, KIT |
BP | GO:0009987; cellular process | GO:0051897; positive regulation of protein kinase B signaling | 2.845E-09 | 3.292E-06 | EGFR, ERBB2, FGFR1, KIT, MET, NOX4, SRC |
MF | GO:0003824; catalytic activity | GO:0046934; phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 5.324E-08 | 5.270E-05 | EGFR, ERBB2, FGFR1, KIT, MET |
BP | GO:0065007; biological regulation | GO:0043406; positive regulation of MAP kinase activity | 1.280E-07 | 9.958E-05 | EGFR, ERBB2, FGFR1, FLT1, KIT, NOX4, SRC |
BP | GO:0065007; biological regulation | GO:0010863; positive regulation of phospholipase C activity | 1.874E-07 | 1.317E-04 | EGFR, FGFR1, FLT1, KIT |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 2.304E-07 | 1.568E-04 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 3.603E-07 | 2.021E-04 | CA2, CA4, CA9, EGFR, ERBB2, HPGD |
BP | GO:0008152; metabolic process | GO:0046854; phosphatidylinositol phosphorylation | 4.112E-07 | 2.035E-04 | EGFR, ERBB2, FGFR1, KIT, MET |
BP | GO:0009987; cellular process | GO:2001028; positive regulation of endothelial cell chemotaxis | 9.568E-07 | 3.472E-04 | FGFR1, KDR, MET |
MF | GO:0005488; binding | GO:0019838; growth factor binding | 1.591E-06 | 5.500E-04 | EGFR, ERBB2, FGFR1, FLT1, KDR |
BP | GO:0009987; cellular process | GO:0071363; cellular response to growth factor stimulus | 1.802E-06 | 6.036E-04 | EGFR, ERBB2, FLT1, KDR, NOX4, SRC |
BP | GO:0009987; cellular process | GO:0014068; positive regulation of phosphatidylinositol 3-kinase signaling | 3.186E-06 | 9.911E-04 | FGFR1, FLT1, KDR, KIT |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.130E-29 | 4.637E-25 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0032502; developmental process | GO:0002009; morphogenesis of an epithelium | 4.060E-06 | 1.211E-03 | CA2, CA9, EGFR, FGFR1, MET, SRC |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.989E-06 | 2.002E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:0070374; positive regulation of ERK1 and ERK2 cascade | 1.215E-05 | 2.896E-03 | ALOX15, EGFR, KDR, NOX4, SRC |
BP | GO:0008152; metabolic process | GO:0043552; positive regulation of phosphatidylinositol 3-kinase activity | 1.334E-05 | 3.091E-03 | FLT1, KIT, SRC |
BP | GO:0009987; cellular process | GO:0038128; ERBB2 signaling pathway | 2.975E-05 | 5.943E-03 | EGFR, ERBB2, SRC |
MF | GO:0005488; binding | GO:0019903; protein phosphatase binding | 3.208E-05 | 6.292E-03 | EGFR, ERBB2, MAPT, MET |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 3.484E-05 | 6.355E-03 | ALOX15, HPGD |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.484E-05 | 6.355E-03 | CA1, CA2 |
MF | GO:0005488; binding | GO:0000166; nucleotide binding | 3.525E-05 | 6.355E-03 | ALDH1A1, EGFR, ERBB2, FGFR1, FLT1, HPGD, KDR, KIT, MET, NOX4, SRC, XDH |
MF | GO:0098772; molecular function regulator | GO:0005088; Ras guanyl-nucleotide exchange factor activity | 3.744E-05 | 6.471E-03 | EGFR, ERBB2, FGFR1, KIT, MET |
MF | GO:0060089; molecular transducer activity | GO:0005021; vascular endothelial growth factor-activated receptor activity | 4.873E-05 | 7.861E-03 | FLT1, KDR |
BP | GO:0008152; metabolic process | GO:0038083; peptidyl-tyrosine autophosphorylation | 5.235E-05 | 8.260E-03 | EGFR, KDR, SRC |
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 6.607E-05 | 9.991E-03 | ALOX15, CA2, EGFR, KDR, KIT, SRC |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.166E-22 | 1.269E-18 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.749E-21 | 2.041E-17 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.314E-28 | 1.065E-26 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04015 | Rap1 signaling pathway | 2.182E-08 | 8.836E-07 | FLT1, SRC, KIT, KDR, MET, EGFR, FGFR1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 4.840E-08 | 1.307E-06 | ERBB2, KIT, MET, EGFR, FGFR1 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 8.015E-08 | 1.623E-06 | SRC, ERBB2, MET, EGFR, FGFR1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 4.922E-07 | 6.644E-06 | SRC, ERBB2, KDR, MET, EGFR, FGFR1 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04510 | Focal adhesion | 4.781E-07 | 6.644E-06 | FLT1, SRC, ERBB2, KDR, MET, EGFR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04014 | Ras signaling pathway | 9.461E-07 | 1.095E-05 | FLT1, KIT, KDR, MET, EGFR, FGFR1 |
09140 Cellular Processes | 09141 Transport and catabolism | hsa04144 | Endocytosis | 2.036E-06 | 2.062E-05 | FLT1, SRC, KIT, KDR, MET, EGFR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04151 | PI3K-Akt signaling pathway | 9.880E-06 | 8.892E-05 | FLT1, KIT, KDR, MET, EGFR, FGFR1 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04060 | Cytokine-cytokine receptor interaction | 4.273E-05 | 3.147E-04 | FLT1, KIT, KDR, MET, EGFR |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 3.124E-05 | 2.530E-04 | SRC, ERBB2, EGFR |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 2.844E-04 | 1.601E-03 | KIT, ERBB2, MET, EGFR, FGFR1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.429E-04 | 9.646E-04 | SRC, MET, EGFR |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 1.625E-04 | 1.012E-03 | MET, EGFR, FGFR1 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 3.170E-04 | 1.605E-03 | ERBB2, EGFR, FGFR1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04012 | ErbB signaling pathway | 2.965E-04 | 1.601E-03 | SRC, ERBB2, EGFR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 4.868E-04 | 2.319E-03 | FLT1, ERBB2, EGFR |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 5.396E-04 | 2.428E-03 | CA2, CA4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Chronic myelogenous leukaemia | C92.1 | SRC; |
I00-I99: Diseases of the circulatory system | Severe coronary heart disease | I25.1 | FGFR1; |
K00-K95: Diseases of the digestive system | Liver disease | K70-K77 | MET; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | FGFR1; ERBB2; |
H00-H59: Diseases of the eye and adnexa | Retinal venous occlusion | H34.8 | ERBB2; |
I00-I99: Diseases of the circulatory system | Heart disease | I00-I52 | MET; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | ERBB2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MET; FGFR1; ERBB2; SRC; |
C00-D49: Neoplasms | Cancer | C00-C96 | MET; FGFR1; ERBB2; SRC; |
I00-I99: Diseases of the circulatory system | Ischemia | I99.8 | SRC; |
C00-D49: Neoplasms | Gastrointestinal cancers | C15-C26 | ERBB2; |
C00-D49: Neoplasms | Glioblastoma multiforme | C71 | ERBB2; SRC; |
C00-D49: Neoplasms | Prostate cancer | C61 | ERBB2; |
C00-D49: Neoplasms | HER2-positive urogenital cancer | NA | ERBB2; |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | MET; |
C00-D49: Neoplasms | Non-hodgkin's lymphoma | C85 | ERBB2; |
C00-D49: Neoplasms | Metastatic HER2-negative gastric cancer | NA | MET; |
K00-K95: Diseases of the digestive system | Chemotherapy-induced mucositis | K12.3 | MET; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Chronic pain | R52.1-R52.2, G89 | ERBB2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoporosis | M80-M81, Z79.890 | SRC; |
C00-D49: Neoplasms | Osteosarcoma | C40-C41 | SRC; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatological disease | L00-L99 | FGFR1; |
C00-D49: Neoplasms | Advanced solid tumor | C00-C75, C7A, C7B | MET; |
C00-D49: Neoplasms | Bladder cancer | C67 | ERBB2; |
C00-D49: Neoplasms | Breast cancer | C50 | ERBB2; |
C00-D49: Neoplasms | Brain cancer | C71, D33 | SRC; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | SRC; |
C00-D49: Neoplasms | Endometrial cancer | C54.1 | FGFR1; |
C00-D49: Neoplasms | Multiple myeloma | C90 | SRC; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | MET; |
I00-I99: Diseases of the circulatory system | Peripheral arterial occlusive disease | I73.9 | FGFR1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Fibrosis | L90.5 | MET; |
C00-D49: Neoplasms | Gastric cancer | C16 | ERBB2; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | ERBB2; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | SRC; |